IL-34 a newly discovered cytokine

  • Maria Luisa Castellani
  • , A. Anogeianaki
  • , P. Felaco
  • , E. Toniato
  • , M. A. De Lutiis
  • , B. Shaik
  • , M. Fulcheri
  • , J. Vecchiet
  • , S. Tetè
  • , V. Salini
  • , T. C. Theoharides
  • , A. Caraffa
  • , P. Antinolfi
  • , S. Frydas
  • , P. Conti
  • , C. Cuccurullo
  • , C. Ciampoli
  • , G. Cerulli

Research output: Contribution to journalReview articlepeer-review

Abstract

In this study we describe some biological effects of IL-34, a newly discovered cytokine. We show that 11-34 stimulates monocyte cell viability and directly modulates the number and function of monocytes and regulates myeloid cell growth and differentiation. Moreover, since IL-34 in mice is involved in osteoporosis, an antagonist of this cytokine could be beneficial for the treatment of this disease.

Original languageEnglish
Pages (from-to)63-66
Number of pages4
JournalEuropean Journal of Inflammation
Volume8
Issue number2
DOIs
StatePublished - 2010
Externally publishedYes

ASJC Scopus Subject Areas

  • Immunology and Allergy
  • Immunology

Keywords

  • Cell differentiation
  • Cytokine antagonists
  • Interleukin-34
  • Monocytes

Fingerprint

Dive into the research topics of 'IL-34 a newly discovered cytokine'. Together they form a unique fingerprint.

Cite this